Thursday, 13 April 2017

Oxford Biomedica (OXB.L) plans biological and economic balance: IG UK

Published on 13 Apr 2017
3 April 2016: Oxford Biomedica CEO, John Dawson, talks to IGTV about how the company plans to manage its debt and relationship with Novartis.

No comments:

Post a Comment